Life Sciences & Pharmaceuticals
Get in touch with our Life Sciences & Pharma team.
Life Sciences Advisory and Accountancy
Providing Life Sciences & Pharmaceutical clients with an adaptable and ambitious advisory team with comprehensive industry knowledge to help grow their business at all stages.
MHA has extensive experience working with organisations across the pharmaceutical industry, from entrepreneurial businesses to large global corporates, including drug manufacturers, wholesalers, medical technologists, and medical device manufacturers.Our Life Sciences & Pharmaceutical accountants and specialists work in partnership with companies at all stages of their life cycle, from launch and growth to maturity and exit. Our global reach and entrepreneurial drive make us the ideal partner for UK pharmaceutical firms.
Our Life Sciences & Pharmaceuticals team provide support on:
Our team helps companies establish robust auditing and monitoring programs that provide insight into the ever-evolving compliance landscape of the life sciences industry. Also, we support companies from start-ups through to those operating internationally with cross-border transactions that crystallise the need for careful tax planning.
Whether you are an emerging life sciences company bringing your first product to market or are an established company with multiple therapies, our team can help you navigate through the commercial and medical needs of your product and business.
Our market access strategy and support services help to create evidence generation plans by analyzing market intelligence and pricing strategies tailored to the needs of each funding jurisdiction.
MHA can advise on operational structures to mitigate risks by evaluating supply chain strengths, correcting weaknesses, and realigning operations to support the business’s strategic objectives.
From understanding how to claim wages, supplies and contract research costs to finding ways to increase and optimize investments in new technologies, our tax and life sciences tax specialists can help maximize the benefits of the R&D tax credits.
We provide advice across a wide range of activities including M&A advisory and business planning, transaction services and due diligence, raising capital, management advisory, business valuations and sales.
MHA’s life sciences industry specialists have a deep understanding of cross-border transactions. They collaborate closely with our tax teams to determine the most effective approach for each situation, aiming to optimise tax mitigation while ensuring compliance with transfer pricing rules and taking into account the implications of Base Erosion and Profit Shifting (BEPS).
Life Sciences & Pharmaceuticals Insight and Events
6 Key Takeaways from our Going Global MedTech Webinar
Full details
Finally, a Budget that matters for Life Sciences
Yogan A. Patel
Government Investment Summit: What the Healthcare and Life Sciences Industries Want to See
Yogan A. Patel
Labour’s Budget Dilemma: Can they power up the UK’s life sciences sector?
David Boosey
Beyond the NHS: Why startups are looking to international markets
Yogan A. Patel
Growing an R&D-intensive life science business
Yogan A. Patel
Why MHA?
- Globally, as member of Baker Tilly, we support 500 medical device, pharmaceutical, life science and biotech companies.
- The pharmaceuticals sector is aligned with our vision of creating a better, more sustainable future for all.
- We build unparalleled relationships with our people, clients, and networks, founded on integrity and trust.
- We help our clients focus on solutions, identifying ways to make things better.
Our Life Sciences & Pharmaceuticals team
Yogan A. Patel
Partner
Full details
Andrew Matthews
Partner
Full details
Rob Dando
Corporate Finance Partner and Transaction Services Leader
Full details
Alicia Crisp
Partner
Full details
Chris Denning
Corporate and International Tax Partner
Full details
Ifzal Rehman
Audit and Accounts Director
Full details
Luke Augur
Audit Manager
Full detailsPharma & Life Sciences Accounting & Consulting
We have extensive experience in working with organisations across the industry, including drug manufacturers, wholesalers, medical technologists, and medical device manufacturers. We support our clients who may be experiencing growth and are looking to expand internationally or are facing significant disruption to aspects of their business, doubling down our focus to help them minimise disruption to achieve strategic and growth objectives.
Globally, we support in the region of 500 medical device, pharmaceutical, life science and biotech companies and as part of our membership of Baker Tilly International we have close links to a large group of consultants based in our North American practice who can advise on wider business and regulatory issues in the sector.
Connected to the sector
We have connections with several of the leading life’s Sciences and Pharmaceuticals across the UK such as the London BioScience Innovation Centre, One Nucleus and BIA
Our specialists frequently take part in delivering key thought leadership that helps drive the sector forward and shapes government policy.
